The Denial Rate Nobody Wants to Talk About
A 2024 industry analysis found that infusion pharmacies are experiencing claim denial rates between 10 and 15 percent. Let that sit for a moment. Roughly one in every ten dollars submitted never gets reimbursed on the first pass, and in many cases, never gets recovered at all. The National Infusion Center Association has identified data quality and documentation inconsistency as primary drivers, pointing specifically to the gap between what lives in dispensing systems and what actually makes it to payers in the format they require.
That gap is not a clinical problem. It is not a staffing problem. It is a data translation problem.
Every claim that goes out with a misaligned code, a missing modifier, or data pulled incorrectly from a dispensing system is a claim that comes back. Every one that comes back requires human time to investigate, correct, and resubmit. And every one that doesn't get corrected in time simply disappears from your revenue picture.
The Invisible Line on Your P&L
Here is the number most pharmacy operators never formally calculate: the fully-loaded cost of their manual data process.
It includes the salary hours spent on extraction, reconciliation, and correction. It includes the opportunity cost of people doing this work instead of something that drives revenue. It includes the error rate inherent in any manual process, which in healthcare revenue cycle compounds quickly. And it includes the downstream cost of decisions made on data that was never fully validated before someone acted on it.
The 2025 Specialty Pharmacy Transformation Outlook Survey from XIFIN found that 70 percent of specialty pharmacy respondents ranked technology and automation as their second-highest opportunity for driving future growth. Second only to patient care. Not because the idea is new, but because the cost of not automating is finally visible in the margin data.
The Manufacturer Rebate Problem
Then there is the revenue most organizations are not counting because they do not know it exists.
Manufacturer hub and data programs carry specific, non-negotiable requirements: precise field formats, defined cadences, validation rules that vary by program and by manufacturer. Submitting late, submitting in the wrong format, or submitting data that fails a validation check on the manufacturer's side means rebate dollars either get delayed or do not come at all.
This is not hypothetical. CMS enforcement actions in 2024 included a $75,000 settlement with one manufacturer for failing to submit timely pricing data, and a $170,000 settlement with another for similar failures. The regulatory infrastructure around pharmacy data submission is tightening, not loosening. Pharmacies on the receiving end of manufacturer programs are subject to the same logic: if the data does not meet the requirement, the value does not come through.
Mosaic was built to close that gap specifically. We identify what each manufacturer requires, validate your data against those standards before it leaves your system, and automate delivery on their schedule. The rebates that manual processes missed do not stay missed.
The Real Math
Consider a mid-size infusion pharmacy running $25 million in annual revenue. At a 12 percent denial rate, that is $3 million in claims that did not clear on the first pass. Even recovering 70 percent of those through manual follow-up still leaves $900,000 on the table, plus the labor cost of chasing the ones that were recovered.
Add in manufacturer rebate leakage, the time cost of a monthly close that takes two weeks instead of two days, and decisions made on data nobody was fully confident in. The number gets uncomfortable fast.
The question is not whether you have a data translation problem. At this scale of complexity, every infusion and specialty pharmacy does. The question is what that problem is actually costing you, and whether you are ready to calculate it honestly.
Next in the series: what happens to your data infrastructure when your organization grows through acquisition, and why most integration strategies fail at the data layer.
See what your data is telling you.
Book a strategic discussion with our team.
Sources:
